(Total Views: 389)
Posted On: 09/11/2022 6:36:51 AM
Post# of 495
Brian Thom continues to keep investors in the loop. What appears to now be a point of emphasis is "Regarding the company’s FDA PMA application process, UHP continues to work with its intended manufacturing partner and its regulatory consultant, Regulatory Compliance Associates , to establish production and complete all necessary documentation. UHP is auditing the production facility as well as its documentation and employee training processes, among other elements of the partner’s operations."
Emphasis to shareholders....."It is anticipated that the completion of the audit process, establishment and inspection of gauze production, drafting of associated documentation, and testing of product to ensure conformance with previous product specifications will be completed within 60 days. In the interim, the company will continue to provide updates on achievement of milestones in this process. "
Is Regulatory Compliance Associates our manufacturing partner and regulatory consultant? Hmmm could be a future buyout/merger?
https://www.rcainc.com/medical-device/
$5-$10+
Emphasis to shareholders....."It is anticipated that the completion of the audit process, establishment and inspection of gauze production, drafting of associated documentation, and testing of product to ensure conformance with previous product specifications will be completed within 60 days. In the interim, the company will continue to provide updates on achievement of milestones in this process. "
Is Regulatory Compliance Associates our manufacturing partner and regulatory consultant? Hmmm could be a future buyout/merger?
https://www.rcainc.com/medical-device/
$5-$10+
(0)
(0)
Scroll down for more posts ▼